No abstract

Methionine sulfoxide reductases (Msrs) are ubiquitous enzymes that reduce protein-bound methionine sulfoxide back to Met in the presence of thioredoxin. In vivo, the role of the Msrs is described as essential in protecting cells against oxidative damages and as playing a role in infection of cells by pathogenic bacteria. There exist two structurally unrelated classes of Msrs, called MsrA and MsrB, specific for the S and the R epimer of the sulfoxide function of methionine sulfoxide, respectively. Both Msrs present a similar catalytic mechanism, which implies, as a first step, a reductase step that leads to the formation of a sulfenic acid on the catalytic cysteine and a concomitant release of a mole of Met. The reductase step has been previously shown to be efficient and not rate-limiting. In the present study, the amino acids involved in the catalysis of the reductase step of the Neisseria meningitidis MsrA have been characterized. The invariant Glu-94 and to a lesser extent Tyr-82 and Tyr-134 are shown to play a major role in the stabilization of the sulfurane transition state and indirectly in the decrease of the pK app of the catalytic Cys-51. A scenario of the reductase step is proposed in which the substrate binds to the active site with its sulfoxide function largely polarized via interactions with Glu-94, Tyr-82, and Tyr-134 and participates via the positive or partially positive charge borne by the sulfur of the sulfoxide in the stabilization of the catalytic Cys.Methionine sulfoxide reductases (Msr) 3 are enzymes that catalyze the reduction of free and protein-bound methionine sulfoxide (MetSO) back to Met. Two structurally unrelated classes of Msrs have been described so far. MsrAs are stereo specific toward the S isomer on the sulfur of the sulfoxide function, whereas MsrBs are specific toward the R isomer. Both classes share a similar three-step catalytic mechanism (Scheme 1). First, the reductase step leads to formation of a sulfenic acid intermediate on the catalytic cysteine concomitantly with the release of one mole of Met/mole of Msr. Then, an intra-disulfide bond is formed via the attack of a second Cys (called the recycling Cys) on the sulfenic acid intermediate accompanied by release of a water molecule. Finally, the disulfide bond is reduced by thioredoxin (Trx) in the last step. Recently, the kinetics of the three steps have been investigated for MsrA and MsrB domains of the PilB protein of Neisseria meningitidis (1, 2). For both classes of Msrs, the rate-limiting step is associated with the Trx recycling process, whereas the rate of formation of the intra-disulfide bond is governed by that of formation of the sulfenic acid intermediate, the rate of which is fast.The three-dimensional structures of the MsrA from Escherichia coli, Bos taurus, and Mycobacterium tuberculosis have been recently solved by x-ray crystallography (3-5). The active site can be represented as an opened basin readily accessible to the MetSO substrate in which the catalytic Cys-51 is located at the entrance of the ␣...

Theoretical computations have been carried out to investigate the reaction mechanism of the sulfoxide reduction by thiols in solution. This reaction is a suitable model for enzymatic processes involving methionine sulfoxide reductases (Msrs). Recent investigations on the Msr mechanism have clearly shown that a sulfenic acid intermediate is formed on the catalytic cysteine of the active site concomitantly to the methionine product. In contrast, experimental studies for the reaction of a number of thiols and sulfoxides in solution did not observe sulfenic acid formation. Only, a disulfide was identified as the final product of the process. The present study has been carried out at the MP2/6-311+G(3d2f,2df,2p)//B3LYP/6-311G(d,p) level of theory. The solvent effect in DMSO has been incorporated using a discrete-continuum model. The calculations provide a basic mechanistic framework that allows discussion on the apparent discrepancy existing between experimental data in solution and in the enzymes. They show that, in the early steps of the process in solution, a sulfurane intermediate is formed the rate of which is limiting. Then, a proton transfer from a second thiol molecule to the sulfurane leads to the formation of either a sulfenic acid or a disulfide though the latter is much more stable than the former. If a sulfenic acid is formed in solution, it should react with a thiol molecule making its experimental detection difficult or even unfeasible.

Hydrogel‐like biomaterials are often too soft to support robust cell adhesion, yet methods to increase mechanical rigidity (e.g., covalent cross‐linking the gel matrix) can compromise bioactivity by suppressing the accessibility or activity of embedded biomolecules. Nanoparticle templating is reported here as a strategy toward porous, layer‐by‐layer assembled, thin polyelectrolyte films of sufficient mechanical rigidity to promote strong initial cell adhesion, and that are capable of high bioactive species loading. Latex nanoparticles are incorporated during layer‐by‐layer assembly, and following 1‐ethyl‐3‐[3‐dimethylaminopropyl]carbodiimide/N‐hydroxysulfosuccinimide (EDC‐NHS) cross‐linking of the polyelectrolyte film, are removed via exposure to tetrahydrofuran (THF). THF exposure results in only a partial reduction in film thickness (as observed by ellipsometry), suggesting the presence of internal pore space. The attachment, spreading, and metabolic activity of pre‐osteoblastic MC3T3‐E1 cells cultured on templated, cross‐linked films are statistically similar to those on non‐templated films, and much greater than those on non‐cross‐linked films. Laser scanning confocal microscopy and quartz crystal microgravimetry indicate a high capacity for bioactive species loading (ca. 10% of film mass) in nanoparticle templated films. Porous nanofilm biomaterials, formed via layer‐by‐layer assembly with nanoparticle templating, promote robust cell adhesion and exhibit high bioactive species loading, and thus appear to be excellent candidates for cell‐contacting applications.

Biomaterials capable of delivering controlled quantities of bioactive agents, while maintaining mechanical integrity, are needed for a variety of cell contacting applications. We describe here a nanotemplating strategy toward porous, polyelectrolyte-based thin films capable of controlled biomolecular loading and release. Films are formed via the layer-by-layer assembly of charged polymers and nanoparticles (NP), then chemically cross-linked to increase mechanical rigidity and stability, and finally exposed to tetrahydrofuran to dissolve the NP and create an intra-film porous network. We report here on the loading and release of the growth factor bone morphogenetic protein 2 (BMP-2), and the influence of BMP-2 loaded films on contacting murine C2C12 myoblasts. We observe nanotemplating to enable stable BMP-2 loading throughout the thickness of the film, and find the nanotemplated film to exhibit comparable cell adhesion, and enhanced cell differentiation, compared with a non-porous cross-linked film (where BMP-2 loading is mainly confined to the film surface).